Regulatory options for pharmacogenetics
- 1 September 2003
- journal article
- Published by Taylor & Francis in Pharmacogenomics
- Vol. 4 (5) , 527-530
- https://doi.org/10.1517/phgs.4.5.527.23802
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- The total artificial heartNature Medicine, 2003
- Pharmacogenomics and reducing the frequency of adverse drug eventsPharmacogenomics, 2003
- Unwarranted variations in healthcare delivery: implications for academic medical centresBMJ, 2002
- Genetic Test Evaluation: Information Needs of Clinicians, Policy Makers, and the PublicAmerican Journal of Epidemiology, 2002
- The Economics of Gene Therapy and of PharmacogeneticsValue in Health, 2002
- Medical Device SafetyPublished by Taylor & Francis ,2002
- Personalized medicine: revolutionizing drug discovery and patient careTrends in Biotechnology, 2001
- PharmacogeneticsHuman Molecular Genetics, 2001
- PharmacogeneticsBritish Medical Bulletin, 1999
- The new genetics: Genetic testing and public policyBMJ, 1998